Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Senti Biosciences (SNTI) Other Operating Expenses (2021 - 2025)

Senti Biosciences has reported Other Operating Expenses over the past 4 years, most recently at $5.1 million for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 1514.06% year-over-year to $5.1 million; the TTM value through Dec 2025 reached $5.1 million, up 1514.06%, while the annual FY2025 figure was $5.1 million, 1514.06% up from the prior year.
  • Other Operating Expenses for Q4 2025 was $5.1 million at Senti Biosciences, up from $313000.0 in the prior quarter.
  • Over five years, Other Operating Expenses peaked at $25.7 million in Q3 2023 and troughed at $1178.0 in Q1 2021.
  • A 4-year average of $6.3 million and a median of $313000.0 in 2024 define the central range for Other Operating Expenses.
  • Biggest five-year swings in Other Operating Expenses: increased 15.5% in 2024 and later surged 1514.06% in 2025.
  • Year by year, Other Operating Expenses stood at $1178.0 in 2021, then surged by 22905.09% to $271000.0 in 2023, then grew by 15.5% to $313000.0 in 2024, then skyrocketed by 1514.06% to $5.1 million in 2025.
  • Business Quant data shows Other Operating Expenses for SNTI at $5.1 million in Q4 2025, $313000.0 in Q4 2024, and $271000.0 in Q4 2023.